An overview of maggot therapy used on chronic wounds in the community

Abstract

Maggot debridement therapy was re-introduced to clinical practice in the UK in the mid 1990s. While at first it was slow to be used by health care professionals, in recent times the therapy has enjoyed an upsurge in use, which has benefited both patients and the NHS. At the same time there has been some resistance to use from clinicians. This led to the introduction of a new presentation of maggots for use in wound care, which has proved popular with both patients and clinicians and has led to increasing use of maggot therapy for the treatment of chronic wounds.